Computational Exploration of Functional and Structural Impact of Single Nucleotide Changes in DNMT3A Gene among Acute Myeloid Leukemia Patients: Single Nucleotide Changes in DNMT3A Gene in AML Patients

Samavia  Abdulhaq; Afia  Muhammad Akram; Khansa  Jamil; Asma  Tahir

doi:10.54393/pbmj.v6i04.882

Authors

Samavia Abdulhaq Department of Zoology, Division of Science & Technology, University of Education, Lahore, Pakistan
Afia Muhammad Akram Department of Zoology, Division of Science & Technology, University of Education, Lahore, Pakistan
Khansa Jamil Department of Zoology, Division of Science & Technology, University of Education, Lahore, Pakistan
Asma Tahir Department of Zoology, Division of Science & Technology, University of Education, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pbmj.v6i04.882

Keywords:

AML, DNMT3A, In silico, SNPs, Prognosis

Abstract

Acute myeloid leukemia (AML) is a blood cell malignancy of the myeloid line, characterized by fast proliferation of aberrant cells that build up in the bone marrow and blood, interfering with normal blood cell synthesis. DNMT3A is a DNA methyltransferase that plays a role in DNA methylation, an epigenetic modification associated with gene expression regulation. DNMT3A mutations are frequently found in AML and are associated with poor prognosis. Objective: To evaluate the impact of DNMT3A mutations on protein structure and function, specifically in the context of AML. Methods: SNPs of DNMT3A gene reported in AML (R882P, R882L, R882S, R882G, and R882C) were retrieved from National Centre for Biotechnology Information (NCBI) database and different in silico approaches were used to investigate how these mutations affect protein structure and function. Results: Prediction tools indicated that mutations are pathogenic affecting DNMT3A function and were found in evolutionarily conserved regions. Protein stability analysis showed that mutations reduce DNMT3A's structural stability, alter secondary structure of the protein, particularly helices, interacts with other proteins and reduce protein-protein affinity. RNA folding analysis revealed abnormal folding patterns caused by mutant, affecting protein translation. DNMT3A expression was reported to be considerably greater in AML compared to normal tissues, and mutations were associated with poor overall survival in AML patients. Methylation levels and post-translational modification sites of DNMT3A were also investigated. Conclusions: Overall, this research highlighted the negative impact of DNMT3A mutations on protein structure and function, emphasizing their importance in the development and prognosis of AML.

References

Heidari A and Gobato R. Evaluating the effect of anti–cancer nano drugs dosage and reduced leukemia and polycythemia vera levels on trend of the human blood and bone marrow cancers under synchrotron radiation. Trends in Research. 2019 Jan; 2(1): 1-8. doi: 10.15761/TR.1000126. DOI: https://doi.org/10.15761/TR.1000126

Bibi N, Sikandar M, Ud Din I, Almogren A, Ali S. IoMT-based automated detection and classification of leukemia using deep learning. Journal of Healthcare Engineering. 2020 Dec; 2020: 1-2. doi: 10.1155/2020/6648574. DOI: https://doi.org/10.1155/2020/6648574

Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: A Cancer Journal for Clinicians. 2014 Jan; 64(1): 9-29. doi: 10.3322/caac.21208. DOI: https://doi.org/10.3322/caac.21208

Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Reviews. 2019 Jul; 36: 70-87. doi: 10.1016/j.blre.2019.04.005. DOI: https://doi.org/10.1016/j.blre.2019.04.005

Williams LA, Garcia-Gonzalez A, Ahaneku HO, Cortes JE, Garcia-Manero G, Kantarjian HM, et al. A patient-reported outcome measure for symptoms and symptom burden of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Blood. 2015 Dec; 126(23): 2094. doi: 10.1182/blood.V126.23.2094.2094. DOI: https://doi.org/10.1182/blood.V126.23.2094.2094

Tebbi CK. Etiology of acute leukemia: A review. Cancers. 2021 May; 13(9): 2256. doi: 10.3390/cancers13092256. DOI: https://doi.org/10.3390/cancers13092256

Estey EH. Acute myeloid leukemia: 2013 update on risk‐stratification and management. American Journal of Hematology. 2013 Apr; 88(4): 317-27. doi: 10.1002/ajh.23404. DOI: https://doi.org/10.1002/ajh.23404

Sergeev AV, Kirsanova OV, Loiko AG, Nomerotskaya EI, Gromova ES. Detection of DNA methylation by Dnmt3a methyltransferase using methyl-dependent restriction endonucleases. Molecular Biology. 2018 Mar; 52: 272-8. doi: 10.1134/S0026893318020139. DOI: https://doi.org/10.1134/S0026893318020139

Khrabrova DA, Yakubovskaya MG, Gromova ES. AML-associated mutations in DNA methyltransferase DNMT3A. Biochemistry (Moscow). 2021 Mar; 86: 307-18. doi: 10.1134/S000629792103007X. DOI: https://doi.org/10.1134/S000629792103007X

Behbahani M, Nosrati M, Moradi M, Mohabatkar H. Using Chou’s general pseudo amino acid composition to classify laccases from bacterial and fungal sources via Chou’s five-step rule. Applied Biochemistry and Biotechnology. 2020 Mar; 190: 1035-48. doi: 10.1007/s12010-019-03141-8. DOI: https://doi.org/10.1007/s12010-019-03141-8

Sadeghi M, Miroliaei M, Fateminasab F, Moradi M. Screening cyclooxygenase-2 inhibitors from Allium sativum L. compounds: in silico approach. Journal of Molecular Modeling. 2022 Jan; 28: 1-2. doi: 10.1007/s00894-021-05016-4. DOI: https://doi.org/10.1007/s00894-021-05016-4

Namadyan N, Seyedalipour B, Hosseinkhani S, Baziyar P. Biochemical and biophysical properties of the novel ALS-linked hSOD1 mutants: an experimental study accompanied by in silico analysis. Journal of the Iranian Chemical Society. 2023 Jan; 20(1): 125-38. doi: 10.1007/s13738-022-02660-2. DOI: https://doi.org/10.1007/s13738-022-02660-2

Brunetti L, Gundry MC, Goodell MA. DNMT3A in leukemia. Cold Spring Harbors Perspectives in Medicine. 2017 feb; 7(2): a030320. doi: 10.1101/cshperspect.a030320. DOI: https://doi.org/10.1101/cshperspect.a030320

Baylin SB and Ohm JE. Epigenetic gene silencing in cancer–a mechanism for early oncogenic pathway addiction? Nature Reviews Cancer. 2006 Feb; 6(2): 107-16. doi: 10.1038/nrc1799. DOI: https://doi.org/10.1038/nrc1799

Yan XJ, Xu J, Gu ZH, Pan CM, Lu G, Shen Y, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genetics. 2011 Apr; 43(4): 309-15. doi: 10.1038/ng.788. DOI: https://doi.org/10.1038/ng.788

Fried I, Bodner C, Pichler MM, Lind K, Beham-Schmid C, Quehenberger F, et al. Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia. Haematologica. 2012 Feb; 97(2): 246. doi: 10.3324/haematol.2011.051581. DOI: https://doi.org/10.3324/haematol.2011.051581

Bruno S, Bochicchio MT, Franchini E, Padella A, Marconi G, Ghelli Luserna di Rorà A, et al. Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia. Journal of Oncology. 2019 Oct; 2019: 5985923. doi: 10.1155/2019/5985923. DOI: https://doi.org/10.1155/2019/5985923

Witham S, Takano K, Schwartz C, Alexov E. A missense mutation in CLIC2 associated with intellectual disability is predicted by in silico modeling to affect protein stability and dynamics. Proteins: Structure, Function, and Bioinformatics. 2011 Aug; 79(8): 2444-54. doi: 10.1002/prot.23065. DOI: https://doi.org/10.1002/prot.23065

Yasmin T. In silico comprehensive analysis of coding and non-coding SNPs in human mTOR protein. Plos One. 2022 Jul; 17(7): e0270919. doi: 10.1371/journal.pone.0270919. DOI: https://doi.org/10.1371/journal.pone.0270919

Aggarwal V, Tuli HS, Varol M, Tuorkey M, Sak K, Parashar NC, et al. NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target. Critical Reviews in Oncology/Hematology. 2021 Aug; 164: 103403. doi: 10.1016/j.critrevonc.2021.103403. DOI: https://doi.org/10.1016/j.critrevonc.2021.103403

Zhou J, Park CY, Theesfeld CL, Wong AK, Yuan Y, Scheckel C, et al. Whole-genome deep-learning analysis identifies contribution of noncoding mutations to autism risk. Nature Genetics. 2019 Jun; 51(6): 973-80. doi: 10.1038/s41588-019-0420-0. DOI: https://doi.org/10.1038/s41588-019-0420-0

Chakravarty D, Janin J, Robert CH, Chakrabarti P. Changes in protein structure at the interface accompanying complex formation. IUCrJ. 2015 Nov; 2(6): 643-52. doi: 10.1107/S2052252515015250. DOI: https://doi.org/10.1107/S2052252515015250

Ferrada E and Wagner A. Protein robustness promotes evolutionary innovations on large evolutionary time-scales. Proceedings of the Royal Society B: Biological Sciences. 2008 Jul; 275(1643): 1595-602. doi: 10.1098/rspb.2007.1617. DOI: https://doi.org/10.1098/rspb.2007.1617

Fujiwara K, Toda H, Ikeguchi M. Dependence of α-helical and β-sheet amino acid propensities on the overall protein fold type. BMC Structural Biology. 2012 Dec; 12(1): 1-5. doi: 10.1186/1472-6807-12-18. DOI: https://doi.org/10.1186/1472-6807-12-18

Trowbridge JJ, Sinha AU, Zhu N, Li M, Armstrong SA, Orkin SH. Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains. Genes & Development. 2012 Feb; 26(4): 344-9. doi: 10.1101/gad.184341.111. DOI: https://doi.org/10.1101/gad.184341.111

Yoo NJ, Kim MS, Lee SH. Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers. Cancer Research. 2012 Apr; 72(8_Supplement): 2191. doi: 10.1158/1538-7445.AM2012-2191. DOI: https://doi.org/10.1158/1538-7445.AM2012-2191

Holz-Schietinger C, Matje DM, Reich NO. Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation. Journal of Biological Chemistry. 2012 Sep; 287(37): 30941-51. doi: 10.1074/jbc.M112.366625. DOI: https://doi.org/10.1074/jbc.M112.366625

Banaszak LG, Giudice V, Zhao X, Wu Z, Gao S, Hosokawa K, et al. Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing. Blood Cells, Molecules, and Diseases. 2018 Mar; 69: 10-22. doi: 10.1016/j.bcmd.2017.12.002. DOI: https://doi.org/10.1016/j.bcmd.2017.12.002

Kapahnke M, Banning A, Tikkanen R. Random splicing of several exons caused by a single base change in the target exon of CRISPR/Cas9 mediated gene knockout. Cells. 2016 Dec; 5(4): 45. doi: 10.3390/cells5040045. DOI: https://doi.org/10.3390/cells5040045

Zhang TJ, Zhang LC, Xu ZJ, Zhou JD. Expression and prognosis analysis of DNMT family in acute myeloid leukemia. Aging (Albany NY). 2020 Jul; 12(14): 14677. doi: 10.18632/aging.103520. DOI: https://doi.org/10.18632/aging.103520

Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, et al. DNMT3A mutations in acute myeloid leukemia. New England Journal of Medicine. 2010 Dec; 363(25): 2424-33. DOI: https://doi.org/10.1056/NEJMoa1005143

Asfour IA, Hegab HM, El-Salakawy WA, Hamza MT, Mansour DA, Saeed AM. Prognostic significance of DNMT3a gene expression and reactive nitrogen species in newly diagnosed Egyptian de novo adult acute myeloid leukemia patients. Egyptian Journal of Medical Human Genetics. 2020 Dec; 21: 1-6. doi: 10.1186/s43042-020-00066-4. DOI: https://doi.org/10.1186/s43042-020-00066-4

Awan FM, Obaid A, Ikram A, Janjua HA. Mutation-structure-function relationship based integrated strategy reveals the potential impact of deleterious missense mutations in autophagy related proteins on hepatocellular carcinoma (HCC): A comprehensive informatics approach. International Journal of Molecular Sciences. 2017 Jan; 18(1): 139. doi: 10.3390/ijms18010139. DOI: https://doi.org/10.3390/ijms18010139

Radivojac P, Baenziger PH, Kann MG, Mort ME, Hahn MW, Mooney SD. Gain and loss of phosphorylation sites in human cancer. Bioinformatics. 2008 Aug; 24(16): i241-7. doi: 10.1093/bioinformatics/btn267. DOI: https://doi.org/10.1093/bioinformatics/btn267

Franz M, Lopes CT, Fong D, Kucera M, Cheung M, Siper MC, et al. Cytoscape. js 2023 update: a graph theory library for visualization and analysis. Bioinformatics. 2023 Jan; 39(1): btad031. doi: 10.1093/bioinformatics/btad031. DOI: https://doi.org/10.1093/bioinformatics/btad031

Hossain MS, Roy AS, Islam MS. In silico analysis predicting effects of deleterious SNPs of human RASSF5 gene on its structure and functions. Scientific Reports. 2020 Sep; 10(1): 14542. doi: 10.1038/s41598-020-71457-1. DOI: https://doi.org/10.1038/s41598-020-71457-1

Yuan XQ, Zhang DY, Yan H, Yang YL, Zhu KW, Chen YH, et al. Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients. Oncotarget. 2016 Sep; 7(37): 60555. doi: 10.18632/oncotarget.11143. DOI: https://doi.org/10.18632/oncotarget.11143